Results 251 to 260 of about 305,738 (309)

Personalized tumor-informed circulating tumor DNA monitoring for early detection of recurrence in postoperative pancreatic cancer. [PDF]

Front Oncol
Chen J, Zou L, Bai X, Tong F, Ni J, Tang H, Liu Y, Kong X, Yin J, Wang F, Sha H, Meng F, Du J.   +12 more
europepmc   +1 more source

A Metal‐Free Carbon Monoxide Prodrug Suppresses Metastasis of Pancreatic and Breast Cancer

Advanced Science, EarlyView.
A metal‐free carbon monoxide (CO) prodrug, CO‐116, delivers controlled systemic CO without inhalation. CO suppresses the HRG1–heme axis, reducing intracellular heme availability. Attenuation of this pathway inhibits metastatic progression in pancreatic and triple‐negative breast cancer models.
Tiantian Zhang, Xiang Chen, Xiaoxiao Yang, Muskan Gori, Rohit Kumar Varshnaya, Dongning Liu, Cheryl Zhang, Michelle Yi Qin Chen, Zhengming Chen, George Zhang, Erika Patel, Qiyue Mao, Tan A. Ince, Chalet Tan, Binghe Wang, Yi‐Chieh Nancy Du   +15 more
wiley   +1 more source

Monitoring of circulating tumor DNA in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy. [PDF]

NPJ Breast Cancer
Cabel L, An JA, Kim HK, Kim J, Smith CG, Chevalier A, Erazo T, Moiso E, Ferraro E, Safonov A, Nelson K, Szuhany K, Drago JZ, Norton L, Xu A, Khan AJ, Li BT, Robson ME, Chandarlapaty S, Plitas G, Razavi P.   +20 more
europepmc   +1 more source

Icariin Enhances the Enzymatic Activity of N‐acetylgalactosaminidase to Augment Akkermansia Abundance in Gut Microbiota for Improved PD‐1 Blockade Efficacy in Tumor Suppression

Advanced Science, EarlyView.
Icariin promoted the growth of Akk by enhancing the activity of N‐acetylgalactosaminidase (Amuc_0920), which enhanced mucin utilization and provided a favorable nutrient environment for bacterial growth. This icariin‐mediated enrichment of Akk further reshaped the tumor microenvironment and promoted CD8+ T cell infiltration, ultimately synergizing with
Shuangying Qiao, Liu Yang, Haibang Hao, Qiuxia Ding, Feng Ding, Zheng Chen, Jinfang Zhang, Yun He, Meng Li, Jun Xu, Chao Wang, Aiping Lu, Fangfei Li   +12 more
wiley   +1 more source

Circulating Tumor DNA as a Biomarker for Precision Medicine in Prostate Cancer: A Systematic Review. [PDF]

Int J Mol Sci
Chanhih N, Laraqui A, Hassine S, Ameur A, Hamedoun L, El Annaz H, Abi R, Tagajdid MR, Amine IL, Ennibi K, Benjouad A, Belayachi L.   +11 more
europepmc   +1 more source

Circulating Tumor DNA (ctDNA) in Gastroesophageal Adenocarcinoma (GEA): Evidence and Emerging Applications. [PDF]

Cancers (Basel)
Sahwan O, Batha L, Jamal F, Sonbol MB.
europepmc   +1 more source

Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors.

JAMA Netw Open
Mahadevia H, Majeed U, Patel J, Ahmed AK, Elhariri A, Albelal D, Rao NNM, Rachamala HK, Mosalem O, Mukhopadhyay D, Jones J, Mahadevan D, Borad MJ, Ahn D, Sonbol MB, Tran N, Mahipal A, Wee Ma W, McWilliams RR, Halfdanarson TR, Kankeu Fonkoua LA, Bekaii-Saab T, Mody K, Babiker H.   +23 more
europepmc   +1 more source

Advances and challenges in circulating tumor DNA-based early detection of lung cancer. [PDF]

Transl Cancer Res
Yoon JK, Park JY, Kim YW, Oh HJ, Kim YC.
europepmc   +1 more source

Assessment of Circulating Tumor DNA for Early Detection of Hepatocellular Carcinoma in Alpha-Fetoprotein-Negative Patients With Cirrhotic Nodules. [PDF]

JGH Open
Chang LJ, Yu MC, Lee WC, Chan FC, Pan YJ, Tai DI, Su WH.   +6 more
europepmc   +1 more source